These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34168192)

  • 21. Significance of AT1 receptor independent activation of mineralocorticoid receptor in murine diabetic cardiomyopathy.
    Nagatomo Y; Meguro T; Ito H; Koide K; Anzai T; Fukuda K; Ogawa S; Yoshikawa T
    PLoS One; 2014; 9(3):e93145. PubMed ID: 24664319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldosterone-induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter.
    Grossmann C; Krug AW; Freudinger R; Mildenberger S; Voelker K; Gekle M
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1790-800. PubMed ID: 17311890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldosterone-induced changes in the cardiac L-type Ca(2+) current can be prevented by antioxidants in vitro and are absent in rats on low salt diet.
    Wagner M; Rudakova E; Volk T
    Pflugers Arch; 2008 Nov; 457(2):339-49. PubMed ID: 18504604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
    Luther JM; Luo P; Wang Z; Cohen SE; Kim HS; Fogo AB; Brown NJ
    Kidney Int; 2012 Sep; 82(6):643-51. PubMed ID: 22622494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldosterone regulation of T-type calcium channels.
    Rossier MF; Lesouhaitier O; Perrier E; Bockhorn L; Chiappe A; Lalevée N
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):383-8. PubMed ID: 12943726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-talk between mineralocorticoid receptor/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes.
    Tsai CF; Yang SF; Chu HJ; Ueng KC
    Int J Cardiol; 2013 Oct; 169(1):17-28. PubMed ID: 24120080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced Ca
    Seidel E; Schewe J; Zhang J; Dinh HA; Forslund SK; Markó L; Hellmig N; Peters J; Muller DN; Lifton RP; Nottoli T; Stölting G; Scholl UI
    Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33879608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
    Hullin R; Métrich M; Sarre A; Basquin D; Maillard M; Regamey J; Martin D
    Cardiovasc Res; 2018 Feb; 114(2):272-281. PubMed ID: 29016737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation.
    Tsai CT; Chiang FT; Tseng CD; Hwang JJ; Kuo KT; Wu CK; Yu CC; Wang YC; Lai LP; Lin JL
    J Am Coll Cardiol; 2010 Feb; 55(8):758-70. PubMed ID: 20170814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DHEA prevents mineralo- and glucocorticoid receptor-induced chronotropic and hypertrophic actions in isolated rat cardiomyocytes.
    Mannic T; Mouffok M; Python M; Yoshida T; Maturana AD; Vuilleumier N; Rossier MF
    Endocrinology; 2013 Mar; 154(3):1271-81. PubMed ID: 23397034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic and rapid effects of aldosterone: what we know and do not know thus far.
    Hermidorff MM; de Assis LV; Isoldi MC
    Heart Fail Rev; 2017 Jan; 22(1):65-89. PubMed ID: 27942913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiRNA-181a is a novel regulator of aldosterone-mineralocorticoid receptor-mediated cardiac remodelling.
    Garg A; Foinquinos A; Jung M; Janssen-Peters H; Biss S; Bauersachs J; Gupta SK; Thum T
    Eur J Heart Fail; 2020 Aug; 22(8):1366-1377. PubMed ID: 32304626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
    Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
    Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
    Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
    Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of hypothalamic angiotensin type 1 receptors in pressure overload-induced mineralocorticoid receptor activation and salt-induced sympathoexcitation.
    Ito K; Hirooka Y; Nakano M; Honda N; Matsukawa R; Sunagawa K
    Hypertens Res; 2013 Jun; 36(6):513-9. PubMed ID: 23364339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epidermal growth factor receptor is involved in angiotensin II but not aldosterone/salt-induced cardiac remodelling.
    Messaoudi S; Zhang AD; Griol-Charhbili V; Escoubet B; Sadoshima J; Farman N; Jaisser F
    PLoS One; 2012; 7(1):e30156. PubMed ID: 22291909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The functional c.-2G>C variant of the mineralocorticoid receptor modulates blood pressure, renin, and aldosterone levels.
    van Leeuwen N; Caprio M; Blaya C; Fumeron F; Sartorato P; Ronconi V; Giacchetti G; Mantero F; Fernandes-Rosa FL; Simian C; Peyrard S; Zitman FG; Penninx BW; de Kloet ER; Azizi M; Jeunemaitre X; Derijk RH; Zennaro MC
    Hypertension; 2010 Nov; 56(5):995-1002. PubMed ID: 20855654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mineralocorticoid Receptor Deficiency in T Cells Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction Through Modulating T-Cell Activation.
    Li C; Sun XN; Zeng MR; Zheng XJ; Zhang YY; Wan Q; Zhang WC; Shi C; Du LJ; Ai TJ; Liu Y; Liu Y; Du LL; Yi Y; Yu Y; Duan SZ
    Hypertension; 2017 Jul; 70(1):137-147. PubMed ID: 28559389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity.
    Schäfer N; Lohmann C; Winnik S; van Tits LJ; Miranda MX; Vergopoulos A; Ruschitzka F; Nussberger J; Berger S; Lüscher TF; Verrey F; Matter CM
    Eur Heart J; 2013 Dec; 34(45):3515-24. PubMed ID: 23594590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mineralocorticoid receptor (MR) regulates ENaC but not NCC in mice with random MR deletion.
    Czogalla J; Vohra T; Penton D; Kirschmann M; Craigie E; Loffing J
    Pflugers Arch; 2016 May; 468(5):849-58. PubMed ID: 26898302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.